Eric Tam

Eric Tam is an Assistant Professor of Clinical Medicine specializing in hematology and oncology. His research focuses on leukemia treatments, stem cell transplantation, and immunotherapy approaches. With extensive publications in hematologic malignancies, he investigates novel therapeutic combinations, transplant protocols, and management of treatment complications.

His research centers on optimizing outcomes for leukemia patients through precision medicine approaches, including targeted therapies like venetoclax and kinase inhibitors. Key interests include CAR-T cell therapy, measurable residual disease detection, and ethnic disparities in transplant outcomes.

Publication analysis reveals predominant focus on hematologic malignancies (88%), particularly acute leukemias (73%). Recent works emphasize immunotherapy integration (31%) and transplant optimization (25%). Methodologies include clinical case studies (56%), retrospective analyses (25%), and literature reviews (19%).